Cure My Disease

Don't miss your cure!

 Log in / Sign up

Wearable ECG patch could unlock hidden heart risks

NCT ID NCT07775976

ENROLLING_BY_INVITATION Knowledge-focused Sponsor: Peerbridge Health, Inc Source: ClinicalTrials.gov ↗

First seen Aug 20, 2026 · Last updated Aug 21, 2026 · Updated 1 time

Summary

This study is testing whether a wearable ECG patch, combined with AI analysis, can help doctors identify a wide range of heart conditions and risks from a single recording. The Cor360 system looks at many aspects of heart health at once, such as heart failure, rhythm problems, and sleep apnea, to create a detailed report for clinicians. Researchers will ask doctors if these reports are useful and whether they change how they would care for their patients. The goal is to see if this technology can provide a more complete picture of heart health than traditional monitoring.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
COR wearable ECG monitoring and AI-enabled decision-support reporting
What this could lead to
If successful, this could give doctors a powerful new tool to detect heart problems earlier and guide more personalized care, potentially preventing serious events like heart failure or sudden cardiac arrest.
What could go wrong
This is an observational study, so it won't prove the system improves health outcomes. The results depend on how well the AI performs in real-world settings, and there's a risk it may not be as accurate or useful as hoped.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARRHYTHMIAS, CARDIAC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Arrhythmias, Cardiac cardiac arrest Cardiac Conduction System Disease cardiac rhythm disease cardiovascular disorder Death, Sudden, Cardiac Edema epilepsy heart conduction disease heart failure myocardial ischemia obstructive sleep apnea syndrome primary dysautonomia sudden cardiac arrest Syncope ventricular fibrillation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ARRHYTHMIAS, CARDIAC ATRIAL CARDIOMYOPATHY BUNDLE/FASCICULAR ABNORMALITIES CARDIAC ARREST (CA) CARDIAC CONDUCTION SYSTEM DISEASE CARDIOPULMONARY CARDIOVASCULAR DISEASES CARDIOVASCULAR DISEASES RISK DECISION SUPPORT SYSTEMS, CLINICAL HEART FAILURE (FOR EXAMPLE, FLUID OVERLOAD) HEART FAILURE - NYHA II - IV HIS-PURKINJE DISEASE HRV MYOCARDIAL ISCHEMIA QT DISPERSION RHYTHM PHENOTYPES SEIZURE DISORDER SLEEP APNEA SYNDROME, OBSTRUCTIVE SUDDEN CARDIAC ARREST SYNCOPE SYNCOPE AND COLLAPSE SYNCOPE RECURRENT VENTRICULAR ARRHYTHMIAS AND CARDIAC ARREST VENTRICULAR FIBRILLATION

Contacts and locations

Locations

  • Peerbridge Health, Inc.

    Pasadena, California, 91107, United States

  • Peerbridge Health, Inc.

    Nashville, Tennessee, 37076, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.